ENTRY       D12721                      Drug
NAME        Avitotamig (USAN)
FORMULA     C8920H13658N2414O2824S66
EXACT_MASS  201888.0905
MOL_WEIGHT  202012.6579
SEQUENCE    (Heavy chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQDIN KYIAWYQHKP GKAPKLLIYY ASNLQPGVPS
            RFSGSGSGRD FTFTISSLQP EDIATYYCLQ YDNLLTFGAG TKLELKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GECTSGGGGS GGGGSGGGGS QVQLVQSGGG
            VVQPGRSLRL SCKASGYTFT RYTMHWVRQA PGKCLEWIGY INPSRGYTNY NQKFKDRFTI
            SRDNSKNTAF LQMDSLRPED TGVYFCARYY DDHYSLDYWG QGTPVTVSSG GGGSGGGGSG
            GGGSGGGGSG GGGSGGGGSD IQMTQSPSSL SASVGDRVTI TCSASSSVSY MNWYQQTPGK
            APKRWIYDTS KLASGVPSRF SGSGSGTDYT FTISSLQPED IATYYCQQWS SNPFTFGCGT
            KLQITR
            (Light chain)
            QVQLQQSGAE VVKPGASVKV SCKASGYSFT DYNMYWVRQA PGQGLEWMGY IDPYKGGTIY
            NQKFQGRATL TRDTSISTAY MELSRLRSDD TAVYYCAREM ITAYYFDYWG QGSSVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYAS
            TYRVVSVLTV LHQDWLNGKE YKCAVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Disulfide bridge: H23-H88, H133-H193, H213-L222, H252-H326, H274-H478, H402-H466, H'23-H'88, H'133-H'193, H'213-L'222, H'252-H'326, H'274-H'478, H'402-H'466, L22-L96, L146-L202, L228-L'228, L231-L'231, L263-L323, L369-L427, L'22-L'96, L'146-L'202, L'263-L'323, L'369-L'427)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of acute myeloid leukemia
TARGET      CD33 (SIGLEC3) [HSA:945] [KO:K06473]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04640(916+945)  Hematopoietic cell lineage
            hsa04658(916)  Th1 and Th2 cell differentiation
            hsa04659(916)  Th17 cell differentiation
            hsa04660(916)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               SIGLEC family
                CD33 (SIGLEC3)
                 D12721  Avitotamig (USAN)
              Other cell surface molecules
               CD molecules
                CD3E
                 D12721  Avitotamig (USAN)
///
